RT Journal Article
SR Electronic
T1 Real-time heart rate variability according to ambulatory glucose profile in patients with diabetes mellitus
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.05.04.23289543
DO 10.1101/2023.05.04.23289543
A1 Im, Sung Il
A1 Bae, Su Hyun
A1 Kim, Soo Jin
A1 Kim, Bong Joon
A1 Heo, Jung Ho
A1 Kwon, Su kyoung
A1 Cho, Sung Pil
A1 Shim, Hun
A1 Park, Jung Hwan
A1 Kim, Hyun Su
A1 Oak, Chul Ho
YR 2023
UL http://medrxiv.org/content/early/2023/05/05/2023.05.04.23289543.abstract
AB Background Autonomic neuropathy commonly occurs as a long-term complication of diabetes mellitus (DM) and can be diagnosed based on heart rate variability (HRV), calculated from electrocardiogram (ECG) recordings. There are limited data on HRV using real-time ECG and ambulatory glucose monitoring in patients with DM.Methods and Results A total of 43 patients (66.3±7.5 years) with DM underwent continuous real-time ECG monitoring (225.7±107.3 hours) for HRV and ambulatory glucose monitoring using a remote monitoring system. We compared the HRV according to the ambulatory glucose profile. Data were analyzed according to the target in glucose range (TIR). There were no significant differences in the baseline characteristics of the patients according to the TIR. During monitoring, we checked ECG and ambulatory glucose levels (a total of 15,090 times) simultaneously for all patients. Both time- and frequency-domain HRVs were lower when the patients had poorly controlled glucose levels (>200 mg/dL) and TIR<70% compared with normally controlled glucose levels (<200 mg/dL) and TIR>70%. In addition, heart and respiratory rates increased with real-time glucose levels (P<0.001).Conclusions Poorly controlled glucose levels were independently associated with lower HRV in patients with DM. This was further substantiated by the independent continuous association between real-time measurements of hyperglycemia and lower HRV. These data strongly suggest that cardiac autonomic dysfunction is caused by elevated blood sugar levels.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was sponsored by a grant from Korea Health Industry Development Institute (KHIDI 20210048001).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the ethical guidelines of the 1975 Declaration of Helsinki, and the research protocol (IRB No. 2022-06-016) was approved by the Ethics Committee of Kosin University Gospel Hospital.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yesall data are available from kosin university gospel hospital (KUGH) Diabetes mellitus registry